quinacrine has been researched along with Dientamoeba fragilis Infection in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolfe, MS | 1 |
| Turner, JA | 1 |
2 reviews available for quinacrine and Dientamoeba fragilis Infection
| Article | Year |
|---|---|
The treatment of intestinal protozoan infections.
Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoeb | 1982 |
Giardiasis and infections with Dientamoeba fragilis.
Topics: Adult; Amebiasis; Animals; Cats; Child; Child, Preschool; Dientamoeba; Dientamoebiasis; Dogs; Female | 1985 |